Biomind Labs Inc.
BMND
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -34.50K | -212.10K | -186.20K | -272.10K | -125.60K |
| Total Depreciation and Amortization | 2.20K | 2.20K | 2.20K | 0.00 | 2.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -56.40K | 103.50K | 75.50K | 153.10K | -3.00K |
| Change in Net Operating Assets | -22.40K | 81.20K | -7.00K | -91.10K | -9.90K |
| Cash from Operations | -111.10K | -25.20K | -115.40K | -210.10K | -136.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 55.80K | 77.60K | 89.30K | 105.80K | 228.70K |
| Total Debt Repaid | -- | -- | -- | 1.00K | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.10K | -- | -- | -- | -- |
| Cash from Financing | 50.70K | 77.60K | 89.30K | 106.80K | 228.70K |
| Foreign Exchange rate Adjustments | 37.40K | -21.20K | 3.90K | -1.50K | -24.30K |
| Miscellaneous Cash Flow Adjustments | -- | -44.50K | 44.50K | -- | -- |
| Net Change in Cash | -23.10K | -13.30K | 22.30K | -104.70K | 68.10K |